Ezhilpavai Mohanan

Christian Medical College & Hospital — India

Medicine · Health Sciences

7h-index188citations35works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(22), Acute Lymphoblastic Leukemia research(17), Acute Myeloid Leukemia Research(11), Chronic Myeloid Leukemia Treatments(9), Chronic Lymphocytic Leukemia Research(5)

Publications35 total

Role of fludarabine exposure on post-transplant outcomes in high-risk β-thalassemia patients undergoing allogeneic HCT with thiotepa/ fludarabine/ treosulfan conditioning
Blood·2025Open Access
Challenges with sirolimus experimental data to inform <scp>QSP</scp> model of post‐transplantation cyclophosphamide regimens
Clinical and Translational Science·2024Open Access
Early Immune Reconstitution Is Similar in Patients with and without Acute GvHD Undergoing Haploidentical HCT with Post-Transplant Cyclophosphamide As Gvhd Prophylaxis.
Transplantation and Cellular Therapy·2024
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation
PLoS ONE·2023· 1 citedOpen Access
Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation
Clinical Pharmacology & Therapeutics·2023· 5 citedOpen Access
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
Frontiers in Immunology·2023· 7 citedOpen Access
Glutathione S-Transferase Gene Promoter Polymorphism (GSTA1*B) Influences Haematopoietic Cell Transplantation (HCT) Outcome in Patients with β-Thalassemia Receiving Treosulfan/Fludarabine/Thiotepa Regimen
Transplantation and Cellular Therapy·2023· 1 citedOpen Access
Lower Treosulfan Systemic Exposure Predicts Graft Rejection in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2022
Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation
Clinical and Experimental Dermatology·2021· 7 cited
A 5’UTR polymorphism in NT5E gene but not fludarabine systemic exposure influences HCT outcome in patients with high-risk β-thalassemia major
2021Open Access
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
Scientific Reports·2020· 11 citedOpen Access
Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
eJHaem·2020· 15 citedOpen Access
Treosulfan Metabolite (S, S-EBDM) Pharmacokinetics Influences Regimen Related Toxicity in Patients with Beta Thalassaemia Major Undergoing HSCT
Blood·2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Clinical Lymphoma Myeloma & Leukemia·2019· 4 citedOpen Access
159 Plasma Elafin as a biomarker for Skin Graft Versus Host Disease
Journal of Investigative Dermatology·2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation·2019· 1 cited
Differential Toxicity Profile of Busulfan and Treosulfan on Endothelial Cells - Relevance to Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation·2019· 2 cited
Targeted Intravenous Vs Oral Busulfan in Very Young Children with Thalassemia Major Undergoing Matched Allogeneic Haematopoietic Stem Cell Transplantation Reduces Graft Rejection without Increasing Toxicity
Biology of Blood and Marrow Transplantation·2019
Targeted IV Vs Oral Busulfan in Very Young Children with Thalassemia Major Undergoing Matched Allogeneic Haematopoietic Stem Cell Transplantation
Blood·2018
Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation·2018· 6 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Vikram Mathews(34), Biju George(30), Poonkuzhali Balasubramanian(30), Alok Srivastava(29), Aby Abraham(24), Kavitha M. Lakshmi(23), Anu Korula(19), John C. Panetta(18), Raveen Stephen Stallon Illangeswaran(15), Aswin Anand Pai(13), Uday Kulkarni(13), Balaji Balakrishnan(12), Anup J. Devasia(11), Eunice Sindhuvi Edison(10), Auro Viswabandya(8), Fouzia NA(7), Bharathi M. Rajamani(5), Ajay Abraham(3), Savitha Varatharajan(3), Sreeja Karathedath(3)